Author(s):
1. Humayun Shahzad:
Clinic, Fauji Fertilizer Company, Sadiqabad
Abstract:
Chronic spontaneous urticaria (CSU) is a chronic and refractory dermatosis. Omalizumab is a relatively new addition to CSU therapeutic armamentarium. We present a 52-year-old male having symptoms of chronic spontaneous urticaria (CSU) of moderate severity for last 15 years. He was on regular H1 antagonist and mast cell stabilizers was started with 300 mg omalizumab on monthly basis, Urticaria activity score started improving after second month. Patient is still using H1 antagonist but not regularly but with a liberal lifestyle as compared to previously.
Page(s):
276-278
DOI:
DOI not available
Published:
Journal: Journal of Pakistan Association of Dermatologists, Volume: 26, Issue: 3, Year: 2016
Keywords:
Chronic spontaneous urticaria
,
omalizumab
References:
References are not available for this document.
Citations
Citations are not available for this document.